PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8134313-1	1993	Spinal and peripheral modulation of pentagastrin-stimulated gastric acid secretion by the pancreatic polypeptide-fold (PP-fold) peptides, neuropeptide Y (NPY), peptide YY (PYY), and pancreatic polypeptide (PP), in urethane-anesthetized rats was evaluated.	Pentagastrin	36-48	peptide YY	Rattus norvegicus	160-170	
2905061-4	1988	Intravenous PYY (130 micrograms/kg-h) inhibited pentagastrin-stimulated gastric acid secretion significantly (P less than 0.05).	Pentagastrin	48-60	peptide YY	Rattus norvegicus	12-15	
2905061-5	1988	Administration of iv PYY resulted in a 41% reduction (P less than 0.05) in pentagastrin-stimulated gastric acid secretion.	Pentagastrin	75-87	peptide YY	Rattus norvegicus	21-24	
8134313-4	1993	Peptide YY and PP (IV) rapidly increased pentagastrin-stimulated gastric acid secretion.	Pentagastrin	41-53	peptide YY	Rattus norvegicus	0-10	
8134313-5	1993	Peptide YY and PP (IT) increased pentagastrin-stimulated gastric acid secretion following administration into the thoracic (T8-T10) region of the spinal cord.	Pentagastrin	33-45	peptide YY	Rattus norvegicus	0-10	
8735621-7	1996	Intracisternal injection of NPY and PYY (0.1-0.5 microgram) did not influence the acid response to pentagastrin but blocked CRF-induced inhibition of pentagastrin-stimulated acid secretion.	Pentagastrin	150-162	peptide YY	Rattus norvegicus	36-39	
8735621-8	1996	NPY(3-36) (0.5 microgram) and PYY(3-36) (0.25 and 0.5 microgram) also completely blocked the inhibitory action of CRF on pentagastrin-stimulated acid secretion.	Pentagastrin	121-133	peptide YY	Rattus norvegicus	30-33	
8735621-14	1996	These results show that both PYY and NPY and the 3-36 forms of PYY and NPY are equipotent in blocking central CRF-induced inhibition of pentagastrin-stimulated gastric acid secretion.	Pentagastrin	136-148	peptide YY	Rattus norvegicus	63-66	
8134313-1	1993	Spinal and peripheral modulation of pentagastrin-stimulated gastric acid secretion by the pancreatic polypeptide-fold (PP-fold) peptides, neuropeptide Y (NPY), peptide YY (PYY), and pancreatic polypeptide (PP), in urethane-anesthetized rats was evaluated.	Pentagastrin	36-48	peptide YY	Rattus norvegicus	172-175	
1971469-2	1990	PYY, infused intravenously at a dose of 800 pmol/kg/h, reduced pentagastrin (20.8 nmol/kg/h) stimulated gastric acid secretion by 34 +/- 3%, whereas in controls acid secretion remained constant throughout the 90 min observation period.	Pentagastrin	63-75	peptide YY	Rattus norvegicus	0-3